PCT4--Chemo Drugs Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Drug/Class | Main side effects |
Fluorouracil Pyrimidine analog | Diarrhea, Hand-Foot syndrome |
Capecitabine (Xeloda) Pyrimidine analog | Hand-Foot syndrome (dose-limiting toxicity) USE: Colon, breast cancers |
Cytarabine (Ara-C) Pyrimidine analog | Neurotoxicity (cerebellar syndrome,), conjuctivitis (use prophylactic steroid eye drops) |
Gemcitabine (Gemzar) Pyrimidine analog | Myelosuppression (affects all 3 lineages, neutropenia prominent); transient rashes (topical/systemic corticosteroids or antihistamines) |
Azacytidine (Vidaza) Pyrimidine analog | Myelosuppression |
Fludarabine (FAMP, Fludara) Purine analog | Myelosuppression (also T-cell depleting, increased risk for opportunistic infection, consider adding prophylactic antibiotics) |
Cladribine (Leustatin) Purine analog | Immunosuppressive (at risk for opportunistic infections) |
6-Mercaptopurine (Purinethol) | Dry rash, hepatotoxicity (may be dose-limiting) |
Methotrexate (Folex) Folate antagonist | Myelosuppression (also T-cell depleting, increased risk for opportunistic infection, consider adding prophylactic antibiotics), CNS toxicity possible, dose-related hearing loss, mucositis! |
Alimta (Pemetrexed) Folate antagonist | Myelosuppression (decreased by folic acid and B12 supplements) |
Vincristine (Oncovin) Vinblastine (Velban) Vinorelbine (Navelbine) Vinca alkaloids | Extravastation, myelosuppression, neurotoxic(esp. Vincristine, dose-limiting), alopecia, FATAL if given intrathecally DOSE: Vincristine max is 2 mg |
Paclitaxel (Taxol) Docetaxel (Taxotere) Taxanes | Hypersensitivity reactions (premedicate with steroid, H1 and H2 antagonists, reaction caused by excipients), alopecia, fluid retention |
Cabazitaxel (Jevtana) Taxane | High cross-reactivity with other taxanes, myelosuppression (requires growth factor support), hypersensitivity (must premedicate) |
Etoposide (VePesid) Topoisomerase II inhibitor | Hypotension (infuse slowly--over 1 hour) |
Ixabepilone (Ixempra) Epothilone | Hypersensitivity (premedicate), caution if patient has cardiac disease (esp. if using with capecitabine) USE: metastatic breast cancer (with capecitabine) |
Topotecan (Hycamtin) Irinotecan (Camptosar) Topoisomerase I inhibitors | Diarrhea (esp. irinotecan--"I run to the can"), use loperamide (4 mg at first sign, 2 mg Q2 hours until diarrhea-free for 12 hours) |
Doxorubicin (Adriamycin) Daunorubicin (Cerubidine) Idarubicin (Idamycin) Anthracyclines | Major nausea and vomiting, myelosuppression, and alopecia! Cardiotoxic! Max lifetime doses: Doxorubicin: 550 mg/m2; Daunorubicin: 900-1000 mg/m2 Extravasation (use DMSO to treat) Dexrazoxane (Zinecard)--cardioprotectant |
Epirubicin (Ellence) Anthracycline | Cardiotoxic (max lifetime dose: 900 mg/m2), less toxic than doxorubicin because of decreased free radical formation |
Mitoxantrone (Novatrone) Anthracenedione | Similar to anthracyclines, less extravasation, nausea/vomiting, alopecia, cardiotoxicity compared to anthracyclines |
Cyclophosphamide (Cytoxan) Ifosfamide (Ifex) Alkylating agents | Myelosuppression, ifosfamide dose-limiting side effect is hemorrhagic cystitis (less in cyclophosphamide), nephrotoxicity Mesna--prevents hemorrhagic cystitis by increasing acrolein excretion |
Cisplatin (Platinol) Carboplatin (Paraplatin) Oxaliplatin (Eloxatin) Platinums | Cisplatin--worst for nephrotoxicity (1-2L NS pre- and post-dose), nausea/vomiting (esp. dose > 60mg/m2), neuropathy (also bad with oxaliplatin, may be exacerbated by cold), ototoxicity, potassium and magnesium wasting; carboplatin suppresses platelets |
Bleomycin (Blenoxane) Antitumor antibiotic | "Blow-mycin", "anti-Lance Armstrong drug", because causes pulmonary toxicity |
Asparaginase Pegaspargase Erwinia asparaginase Antitumor enzyme | Lower risk of hypersensitivity with pegylated, pancreatitis, monitor clotting function |
Trastuzumab (Herceptin) MAB | USE: Breast cancer Cardiomyopathy (must evaluate left ventricular function pre- and during treatment), infusion-related reactions (pre-treat with APAP and Benadryl) |
Alemtuzumab (Campath) MAB | USE: B-cell CLL Inusion-related reactions (premedicate), prolonged myelosuppression (need prophylaxis up to 6 months afterwards) |
Cetuximab (Erbitux) MAB | USE: Colorectal, head and neck cancer Acne-form rash (signature!) on face and torso, reversible |
Bevacizumab (Avastin) MAB | USE: Colorectal, lung cancer Most serious side effect is GI perforation/bleeding (only ~2%), severe hypertension (caution in patients with PMH, treat with antihypertensives) |
Panitumumab (Vectibix) MAB | USE: Colorectal cancer Rash (sunscreen and moisturizers), infusion reactions not as common, electrolyte abnormalities (monitor) |
Gemtuzumab (Mylotarg) MAB | USE: CD33 and AML Severe mylosuppression (all 3 cell lines), hypersensitivity and infusion-related reactions (pretreat with APAP/Benadryl), hepatotoxic, pulmonary toxicity |
Rituximab (Rituxan) MAB | USE: lymphoma, rheumatoid arthritis, leukemia Hypersensitivity reactions (do not re-try agent if these occur, stop infusion and give epinephrine, antihistamines, corticosteroids), infuse slowly, tumor lysis syndrome |
Created by:
100000197460889
Popular Medical sets